Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.
Pharmaceutical companies have already raised the price of over 800 brand-name prescription drugs this year. Nearly all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback